Differentiation between Glioblastomas and Cerebral Metastases using High-Resolution 3D MRSI

Differentiation of IDH Mutant from IDH wild-type High-grade Gliomas using Combined Analysis of Diffusion and Perfusion MRI

Discrimination between lower-grade glioma and glioblastoma with amide proton transfer and diffusion kurtosis imaging at 3 Tesla

The Effect of Tumor Grade within IDH Wild-Type and IDH Mutant Gliomas Assessed by Proton Magnetic Resonance Spectroscopy at 3T

Glioma 2HG threshold setting based on normal appearing white matter increases the diagnostic value of 3D MEGA-LASER for IDH mutation detection

Initial experience: detection of aberrant HP-13C metabolism in patients with glioblastoma prior to resection

Long-Term Monitoring of Brain Tumors Using MR Metabolic Phenotyping

Metabolic characterization of human glioma subtypes using simultaneous pH- and oxygen-sensitive amine CEST-SAGE-EPI

Radiomics profiling identifies the incremental value of MRI features to key molecular biomarkers for risk stratification of high-grade gliomas

Sodium MRI at 7 Tesla as quantitative biomarker to assess tumor heterogeneity and histologic subtypes in glioma patients